Intracranial self-stimulation mitigates spatial task deficits, modifies miR-146a and miR-495 serum levels and restores hippocampal NRF2 levels in a rat model of sporadic Alzheimer's disease.

Introduction: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease associated with aging. While deep brain stimulation (DBS) shows therapeutic promise, the long-term persistence of its effects remains understudied. Expression patterns of circulating miRNAs, proposed diagnostic bi...

Descripción completa

Detalles Bibliográficos
Publicado en:Frontiers in Aging Neuroscience pp. 1 - 20
Autores principales: Riberas-Sánchez, Andrea, García-Brito, Soleil, Vila-Solés, Laia, Aldavert-Vera, Laura, Segura-Torres, Pilar, Huguet, Gemma, Carreras-Badosa, Gemma, Kádár, Elisabet
Formato: pictorial research tables/charts Journal Article
Publicado: Frontiers Media S.A. 2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189571065&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189571065
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        16634365
        BG2U
      jtl: Frontiers in Aging Neuroscience
      issn: 16634365
      maglogo: N
    pubinfo:
      dt: 2025
      pid: 40038
      pub: Frontiers Media S.A.
    artinfo:
      ui:
        189571065
        189571065
        189571065
        10.3389/fnagi.2025.1671196
        189571065
      ppf: 1
      ppct: 19
      formats:
      tig:
        atl: Intracranial self-stimulation mitigates spatial task deficits, modifies miR-146a and miR-495 serum levels and restores hippocampal NRF2 levels in a rat model of sporadic Alzheimer's disease.
      aug:
        au:
          Riberas-Sánchez, Andrea
          García-Brito, Soleil
          Vila-Solés, Laia
          Aldavert-Vera, Laura
          Segura-Torres, Pilar
          Huguet, Gemma
          Carreras-Badosa, Gemma
          Kádár, Elisabet
        affil: Grup de Neurobiologia Cel·lular i Molecular, Departament de Biologia, Universitat de Girona, Girona, Spain
      sug:
        subj:
          Alzheimer's Disease
          Deep Brain Stimulation
          Spatial Perception Evaluation
          Task Performance and Analysis Evaluation
          MicroRNA Metabolism
          NF-E2-Related Factor 2
          Models, Biological
          Biological Markers
          Gene Expression Profiling
          Memory
          Funding Source
          Animal Studies
          Rats
          Experimental Studies
          Descriptive Statistics
          Aging
          Signal Transduction
          Cognition Disorders
          Reverse Transcriptase Polymerase Chain Reaction
          Blotting, Western
          Data Analysis Software
          Two-Way Analysis of Variance
          Kruskal-Wallis Test
          T-Tests
          Mann-Whitney U Test
          Spearman's Rank Correlation Coefficient
          Bivariate Statistics
          Confidence Intervals
      ab: Introduction: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease associated with aging. While deep brain stimulation (DBS) shows therapeutic promise, the long-term persistence of its effects remains understudied. Expression patterns of circulating miRNAs, proposed diagnostic biomarkers, and their modulation by DBS are still poorly characterized in longitudinal studies. This study investigates the effect of a 13-week prolonged ICSS treatment on spatial memory and serum miRNA expression in a male rat model of sporadic AD (SAD) by intracerebroventricular injection of streptozotocin (STZ). Methods: Morris water maze (MWM) tasks were conducted at 1 and 5 months post-STZ. Serum miRNA levels were quantified by qRT-PCR at 29 (Ser0), 73 (Ser1) and 136 (Ser2) days after STZ administration. Corpus callosum thickness and NRF2 protein levels in the hippocampal CA1 region were assessed using Nissl staining and immunohistochemistry, respectively. Target validation of miR-495 was performed via transfection assays in the human neuroblastoma SH-SY5Y cell line. Results: MFB-ICSS treatment significantly reduced escape latency in the MWM task in the STZ + ICSS group compared to untreated STZ rats at 5 months post-STZ. At Ser0, levels of miR-16, miR-30c, miR-181, miR-191 and miR-196a were significantly increased in STZ group. In STZ rats, miR-146a and miR-495 levels increased from Ser1 to Ser2, an effect not observed in the Control or STZ + ICSS groups. In SH-SY5Y cells, miR-495 overexpression significantly downregulated both NRF2 mRNA and protein levels. Moreover, STZ exposure increased miR-495 and reduced NRF2 protein levels. MFB-ICSS also reversed the STZ-induced reductions in both CA1 NRF2 levels and corpus callosum thickness. Conclusion: Prolonged MFB-ICSS treatment mitigates cognitive deficits, modulates circulating levels of miRNA-495 and miR-146a, restores hippocampal NRF2 levels, and preserves corpus callosum integrity in the SAD rat model by STZ injection. These findings highlight the therapeutic potential of MFB-ICSS as a non-pharmacological intervention in AD. Furthermore, this study confirms NRF2 as a target of miR-495 in the context of AD.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N